Volume number60巻2号 2011年
プラチナ製剤・タキサ...

プラチナ製剤・タキサン製剤耐性再発上皮性卵巣癌・卵管癌・腹膜癌に対するPegylated liposomal doxorubicin(PLD)の有用性および副作用の検討

Icons representing 記事

プラチナ製剤・タキサン製剤耐性再発上皮性卵巣癌・卵管癌・腹膜癌に対するPegylated liposomal doxorubicin(PLD)の有用性および副作用の検討

Call No. (NDL)
Z74-F552
Bibliographic ID of National Diet Library
023942754
Material type
記事
Author
光井 崇ほか
Publisher
[広島] : 日本産科婦人科学会中国四国合同地方部会
Publication date
2011
Material Format
Paper
Journal name
現代産婦人科 60(2):2011
Publication Page
p.265-269
View All

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
記事
Author/Editor
光井 崇
児玉 順一
関 典子 他
Alternative Title
Clinical utility and adverse effects of PEGylated liposomal doxorubicin (40mg/m²) in platinum/paclitaxel-resistant carcinoma of the ovary, fallopian tube, and peritoneum
Periodical title
現代産婦人科
No. or year of volume/issue
60(2):2011
Volume
60
Issue
2
Pages
265-269